Discussion
Lower levels of a rare gut bacterium called Akkermansia massiliensis may increase the risk of multiple sclerosis (MS) by reducing the activity of an immune-regulating gene called FcRL3, offering researchers potential new therapeutic targets, according to a genetic study. “The FcRL3 protein plays a key role in linking specific…